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Renal mesangium is a target for calcitonin gene-related peptide
ARMIN KURTZ, HANS-JOACHIM SCHUREK, WOLFGANG JELKMANN, ROMAN MUFF,
HANS-PETER Lipp, UWE HECKMANN, KAI-UWE ECKARDT, HOLGER SCHOLZ, JAN A. FISCHER,
and CHRISTIAN BAUER
Physiologisches and Anatomisches Institut der Universität Zurich, and Forschungslabor fur Calciumstoffwechsel und Departemen: für Innere
Medizin, Orthopadische Universitatsklinik, Zurich, Switzerland; Abteilung Nephrologie, Medizinische Hochschule Hannover, and
Physiologisches Institut, Medizinische Hochschule Lubeck, Federal Republic of Germany
Renal mesangium is a target for calcitonin gene-related peptide. Rat
calcitonin gene-related peptide (CGRPa; EC50, I nM) was shown to
stimulate cAMP formation in cultured rat renal mesangial cells. CGRP
concentration dependently (EC,0, 1 nM) also inhibited contraction of
mesangial cells by angiotensin 11(10 nM). Angiotensin 11(10 nM) caused
a transient increase of the intracellular calcium concentration from 140
nM to 480 nss in the mesangial cells, but these calcium transients were
not altered by CGRP. CGRP (10 nM) decreased vascular resistance in
the isolated rat kidney perfused at constant pressure (100 mm Hg; P <
0.01). The decreased vascular resistance was accompanied by a rise of
the glomerular filtration fraction. CGRP, moreover, attenuated the
effects of angiotensin II on renal vascular resistance and glomerular
filtration (P < 0.01). In conclusion, CGRP causes relaxation of renal
mesangial cells and decreases renal vascular resistance. As a result
CGRP raises glomerular filtration and the filtration fraction. The effect
may be linked to cyclic AMP formation. Thus, regulation of renal
vascular and glomerular function may represent a novel action of CGRP
apart from its cardiovascular effects.
Calcitonin gene-related peptide (CGRP) [1] is a 37 amino acid
polypeptide synthetized as a result of tissue specific processing
of the primary RNA-transcript of the calcitonin gene [1—4].
CORP has been identified in the central and peripheral nervous
system [2, 3], and it is considered to act as neurotransmitter or
neuromodulator [5, 6], but CGRP is also present in thyroid
C-cells [7]. Important actions of CGRP are on the cardiovascu-
lar system where CGRP causes vasodilation, and has positive
chronotropic and inotropic effects on the heart [8—12]. Re-
cently, CGRP was shown to directly stimulate renin secretion in
renal juxtaglomerular cells [131. To this end, CGRP immuno-
reactive nerve fibers were recognized in the proximity of renal
glomeruli [131. This localization indicates that CGRP may affect
glomerular function through relaxation of mesangial cells. Since
mesangial cells are modified vascular smooth muscle cells, and
CGRP causes vasodilation, it seemed reasonable to assess the
effect of CGRP on the function of mesangial cells. We have
therefore examined the effect of rat CGRPa on cAMP formation
and contractility of cultured rat mesangial cells. In addition, the
effect of rat CGRPa on renal vascular resistance and glomerular
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filtration in the isolated perfused rat kidney was investigated.
The results suggest that CORP causes a cAMP mediated
relaxation of renal mesangial cells, and as a result increases the
glomerular filtration rate.
Methods
Cultures of rat mesangial cells
Rat mesangial cells were cultured as described previously
[14]. Briefly, renal glomeruli from male Sprague-Dawley rats
were isolated by a sieving procedure. Isolated glomeruli were
seeded in 75 cm2 flasks and 7 cm2 petri dishes in RPMI 1640
medium supplemented with 10% fetal bovine serum, 1 mg/mI
insulin and 100 sg streptomycin and 100 IU penicillin per ml,
and were incubated at 37°C in a humidified atmosphere of 5%
CO2 in air. Twenty-one days after seeding, the cells were
passaged for the first time using trypsin-EDTA. For the exper-
iments mesangial cells from the primary culture and the first
passage were used.
Cyclic 3', 5'-AMP measurements
For determination of cAMP accumulation the culture me-
dium was withdrawn and replaced by Leibovitz-Medium (L-15)
supplemented with 0.5 mivi 3-isobutyl-1-methyl-xanthine
(IBMX) and graded amounts of rat CGRPa. The culture dishes
were placed on a heating block at 37°C. After incubation for 10
minutes the L-15 medium was withdrawn, and the dishes were
placed on an ice block. Ice-cold buffer (0.4 ml) containing 5 mrs'i
potassium phosphate, 2 mi EDTA, 0.5 m IBMX and 150 mM
KC1, pH 6.8 were then added, and the cells were scraped with
a teflon policeman. The obtained suspension was sonicated,
boiled for five minutes and centrifuged. The supernatants were
assayed for cAMP using a specific binding assay [15]. The
pellets were lysed with 1 N NaOH and used for protein
determination [16]. The L-15 medium withdrawn at the end of
the incubations was centrifuged, and the supernatants were also
assayed for cAMP.
Contraction studies
Mesangial cell cultures, grown in 2 cm2 culture trays (24-well;
Nunc, Wiesbaden, FRO), were washed twice, and incubated
for two minutes at 37°C in Hanks' balanced salt solution
(without bicarbonate, pH 7.2) supplemented with 1 m cal-
cium, 0.1% bovine serum albumin and graded amounts of
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CGRPa. Angiotensin II was then added at a final concentration
of 10 nM. Shape changes of the cells were followed by phase
contrast microscopy. Mesangial cell shape changes were stud-
ied four minutes after the addition of angiotensin II, because
recent studies indicate that angiotensin induced contraction
may be followed by autogeneous relaxation after 10 to 30
minutes [17].
Photomicrographs were enlarged to a final magnification of
3000 and the contors of the cells were copied onto transparent
paper. Areas and perimeters of the cells were determined by
tracing these contors on a graphic tablet Hewlett-Packard (HP)
9lllA by a morphometrical and graphic software written in
HP-BASIC. The algorithms to determine areas and perimeters
were based on routines provided by R.R. Mize [18].
Calcium measurements
Trypsin-EDTA dispersed rat mesangial cells were loaded for
20 minutes at 37°C with 1 M fura-2/AM in a medium contain-
ing: 137 mivi NaCI, 5.5 ms'i KCI, 0.8 mri Na2HPO4, 1 mrvt CaCl2,
1 mM MgSO4, 0.01 mr'i diethyltriaminopentaacetic acid, 20 mM
Hepes, pH 7.45, and supplemented with 0.1% glucose and 0.1%
BSA essentially as described [19]. Washed cells were incubated
for an additional 10 minutes at 37°C in medium without fura-
2/AM. Loaded cells were kept at room temperature until
fluorescence measurements were performed. Fluorescence was
measured at 37°C by spectrofluorimetry (Perkin Elmer 650-10 S,
Norwalk, Connecticut, USA) with respective excitation and
emission wavelengths of 340 nm and 500 nm, and slit widths of
4 nm and 10 nm. The fura-2 signal was calibrated by the addition
of 50 tM digitonin for Fmax and 20 mvi EGTA, pH 8.5 for Fmin.
(Ca2)1 was calculated from the equation: (Ca2), = Kd(F —
Fmin)/(Fmax — F), assuming a Kd of 224 nM.
Isolated perfused rat kidney
Male Wistar rats (260 to 290 g) were fed a commercial chow
(Altromin standard pellets). Isolated rat kidneys were perfused
as described [20]. Effective perfusion pressure was held con-
stant at 100 mm Hg by feedback regulation of the perfusion
pump. The pressure signal was taken through the inner part of
a double barreled cannula within the aorta directly at the origin
of the renal artery. The basic perfusion medium was Krebs-
Henseleit physiologic saline with 8.7 m glucose and 5%
bovine serum albumin. A mixture of substrates and amino
acids, and a 5 to 6% hematocrit fraction of freshly drawn and
five-times-washed human erythrocytes were added. The perfus-
ate (200 ml at the beginning, 150 ml during recirculation) was
dialyzed continuously against 5000 ml of a protein free solution
which was gassed with 95% 02 and 5% CO2. The basic medium
(perfusate and dialysate) contained 0.3 mrvi pyruvate, 2.0 mM
L-lactate, 1.0 mvi a-ketoglutarate, 1.0 mrvi maleate, 6.0 mM
urea, and 21 physiological amino acids in concentrations be-
tween 0.2 m and 2 mri. Neomycin-sulfate (10 mg/liter),
polyfructosan (1 g/liter) and antidiuretic hormone (10 mU/liter)
were also added. An in-line filter (12 tm pore size) was used
during the preperfusion period, before erythrocytes had been
added. Angiotensin II and rat CGRPa, dissolved in freshly
drawn dialysate, were infused in front of the kidney into a
micro-magnetic stirrer chamber. The flow signal of the perfu-
sion pump was used to achieve a flow proportional infusion rate
of 1% of the flow rate. For parallel two electronically-regulated
pumps were used (workshop adaption of an injectomat, Frese-
nius, Homburg, FRG).
Sodium and potassium were analyzed by flame photometry
(IL 543 digital flame photometer) with an internal lithium
standard. Osmolality was measured by a Wescor vapor pres-
sure osmometer. Glucose was measured by hexokinase/glu-
cose-6-phosphate dehydrogenase method [211, and polyfruc-
tosan after acid hydrolysis by a phosphohexose isomerase
reaction. Glomerular filtration rate was determined from the
polyfructosan clearance rate.
Materials
Cell culture media, penicillin-streptomycin, pyruvate and the
enzymes used for polyfructosan and glucose analysis were
obtained from Boehringer (Mannheim, FRG). Fetal bovine
serum was from Gibco (Karlsruhe, FRG). Insulin, trypsin,
angiotensin II, and bovine serum albumin were purchased from
Sigma International, and fura-2AM from Calbiochem. Glu-
tamine, a-ketoglutarate and malate was provided by Merck
(Darmstadt, FRG), L-lactate as sodium salt by Serva (Heidel-
berg, FRG) and neomycin sulfate by Byk-Gulden (Konstanz,
FRG). L-amino acids were purchased from Braun/Melsungen,
(FRG, aminoplasmal paed. free of carbon hydrates). Polyfruc-
tosan was supplied by Laevosan (Salzburg, Austria and ADH
as Pitressin (aqueous solution) from Parke-Davis (Munich,
FRG). Rat CGRP-a was obtained from Peninsula Laboratories
(Belmont, California, USA).
Results
Incubation of cultured rat mesangial cells with rat CGRPc
enhanced cellular and extracellular cAMP accumulation (Fig.
1). The EC50 of cellular cAMP formation was 1 nM. At a
concentration of 1 nM we also examined the effects of salmon
and rat calcitonin on cAMP formation in comparison with that
of CGRPa. Basal cAMP formation was 4.3 0.8 pmol cAMP
per 10 minutes and mg of protein (mean SEM of five
experiments), and 19.8 2.0, 5.9 0.5, and 4.4 0.9 in
presence of rat CGRPa, salmon calcitonin and rat calcitonin,
respectively.
There is evidence that cAMP is able to attenuate the contrac-
tility of mesangial cells [22—241. We therefore examined the
effect of CGRP on the contraction of cultured rat mesangial
cells brought about by angiotensin II (A II). In Figure 2 cells
responding typically to All (10 nM) are shown. Contraction was
quantitated by measuring planar cellular surface and planar
cellular circumference. Four minutes after addition of All
planar surface and circumference of the cells were significantly
reduced by 38% and 36%, respectively, in the absence of
CGRP. Two minutes of preincubation with CGRP concentra-
tion dependently (EC50, 1 nM) attenuated the reduction of
planar surface and circumference in response to All (Fig. 3). At
10 rIM CGRP the contraction evoked by 10 flM All was blunted.
Raised cytosolic calcium in mesangial cells after addition of
All is considered to be an essential step through which All
causes contraction [25]. Even though CGRP reduced the con-
traction brought about by All, the amplitude and the duration of
cytosolic calcium responses remained unchanged (Fig. 4, Table
1). It was confirmed in control experiments that CGRP in-
creases cAMP formation also in trypsinized cells used for the
calcium measurements.
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Fig. 1. Dose response curve for rat CGRPa on accumulation of
intracellular (•) and extracellular (0) cAMP in cultured rat renal
mesangial cells. Data are means of quadruplicates. Maximal stimula-
tion of cAMP formation by CGRP as determined in four different
culture preparations ranged between 9.5- to 21-fold over basal.
Table 1. Effect of rat CGRPa on rise of the (Ca2)1 in response to
All (10 nM) in rat renal mesangial cells
Concentration
of CGRPa M
r' 2a +\, flM
Basal Peak
0 141±9 47562b
10_s 138 14 427 86'i0 156 3 548 96a,b
10—6 135 12 469 74a.b
Results are means SEM of four determinations.
a P> 0.1 vs. control group.
bP < 0.001 vs. basal values (paired t-test).
Effects of CGRP in the absence and presence of All were,
moreover, analyzed in the isolated perfused rat kidney. Figure
5 demonstrates the effect upon perfusion flow rate at a constant
effective perfusion pressure (100 mm Hg). After a control phase
All was first examined. All (24 pM) caused a significant
decrease of flow rate, glomerular filtration and filtration fraction
(Fig. 5, Table 2). With CGRP (10 nM) alone, both the flow rate
and GFR increased (Fig. 5, Table 2). The filtration fraction rose
from 4.15% 0.47% to 5.16% 0.43%. When CGRP (10 nM)
and All (24 pM) were infused together, the effects of All were
blunted. It should be noted that the effects of All were not
subject to homologous desensitization (insert in Fig. 5). Even
when CGRP was withdrawn and infusions with All were
continued, the flow rate and GFR did not return immediately to
control values, which indicates prolonged action of CGRP. All
Fig. 2. Shape of cultured rat renal mesangial cells before, 2 and 4
minutes after the addition of 10 nMAII.
and CGRP alone had opposite effects on urinary flow rates.
They were decreased during infusions of All, and were doubled
in response to CGRP. Though CGRP raised GFR from 1.04
0.08 to 1.34 0.07 mI/mm per g kidney, fractional sodium
reabsorption decreased only from 90 to 85.3% when the filtered
sodium load was increased from 134 to 163 tmolImin per g.
Free water reabsorption in this phase was increased out of
proportion during CGRP infusion, and was blunted after sub-
sequent addition of All.
In addition we measured the renin activity in the venous
effluate during the experimental periods. As documented in
Table 2 CGRP enhanced renin secretion in the isolated perfused
rat kidney.
Discussion
Here we have examined effects of CGRPa on rat renal
mesangial cells. Much like in blood vessels, the heart and the
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Fig. 3. Percentage of change of planar surface area (S) and circum-
ference (0) of cultured rat renal mesangial cells five minutes after
addition of 10 nr.i angiotensin II. Cells were preincubated for two
minutes with different concentrations of rat CGRPa. Data are mean
SEM of 13 to 20 experiments. Area and circumference of cells before the
addition of angiotensin II were 4026 1083 m2 and 584 105 sm
(mean SEM; N = 13), respectively. Both parameters were not
significantly altered by preincubation with rat CGRPa (P > 0.1).
Percentage of cells contracting in response to All was 69%, 72%, 45%,
20% and 10% after preincubation with 0, 0.1 nM, 1 nM, 10 n and 100
nM CGRP, respectively.
spleen [26-28] CGRP stimulated cAMP formation in mesangial
cells. In view of the structural homology between CORP and
calcitonin and the cross tachyphylaxis observed between the
NN
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Fig. 4. Recordings of cytosolic calcium concentrations in suspensions
of rat renal mesangial cells after subsequent addition of rat CGRPX
and angiotensin II (10 nM).
Table 2. Functional parameters of the isolated perfused rat kidney at constant pressure (effective aortic pressure 100 mm Hg)
Midpoint of time mt. Control All Control CGRP CGRP/AII All
miii 54 73 87 101 114 125
RVR mm Hg. mm g 4.21 0.23 5.81a 0.44 4.07 0.28 3.6la 0.22 4.08 0.23 4.22 0.27
per ml
GFRullmun.g 1124±43 791a±57 1041 1342a±72 1162±75 1054±62
FF % 5.08 0.28 4.62a 0.26 4.15 0.47 5.16a 0.43 4.70 0.35 4.37 0.22
UF pilmin . g 69.0 20.4 46.2 99a 119 23.3 213 38.Sa 194 25 188 19.7
UNa p.unol/min . g 6.73 0.28 4.32 0.31a 13.4 1.0 24.0 l.3a 22.1 1.7 20.5 1.2
RA ngAI/h . ml 6.43 1.28 6.40 1.4 6.85 0.43 21.9 2.l8a 20.1 4.20 20.8 3.40
Concentrations of All and CGRP were 24 PM and 10 n, respectively. Data are means SEM of 7 experiments. Abbreviations are: RVR, renal
vascular resistance; GFR, glomerular filtration rate; FF, filtration fraction; UF, urinary flow; UNa, urinary sodium excretion; RA, renin activity
in venous effluate. Midpoints of time intervals are indicated in Figure 5.
a P < 0.05 vs. respective control.
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10—10 io— 10_8 two peptides, it was essential to also investigate possible effects
of rat and salmon calcitonin on cAMP formation in the same
cells. On a molar basis CORP was more active in stimulating
cAMP production than salmon calcitonin and rat calcitonin was
inactive. We infer from these results that activation of adenyl-
ate cyclase in mesangial cells is mediated by specific receptors
for CORP rather than for calcitonin. This conclusion is sup-
ported by the observation that calcitonin receptors could not be
demonstrated in renal glomeruli [291.
There is evidence that elevations of cAMP in mesangial cells
are capable to attenuate contraction [22—241. In control exper-
iments we observed that a 30 minute preincubation of mesangial
with 500 tM dibutyryl cAMP reduces the percentage of cells
contracting upon angiotensin 11(10 nM) from 52% to 9%. Our
observation that among different cell preparations between 50%
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to 70% of the cells contract in response to All is in accordance
with previous reports [17, 251. We also examined CGRP caused
relaxation of mesangial cells contracted with angiotensin II.
The numerical similarity of EC50 values of cAMP production
and inhibition of contraction by All are consistent with a close
linkage between activation of adenylate cyclase by CGRP and
relaxation of mesangial cells.
The contraction of vascular smooth muscle cells and mesan-
gial cells by All is initiated by a transient rise of the cytosolic-
free calcium concentration 1251. Nevertheless, CGRP did not
alter the calcium transients, although it enhanced cAMP forma-
tion. This suggests that CGRP did not affect (Ca)1 and therefore
the generation of the essential second messenger of All. CGRP
therefore may inhibit contraction of mesangial cells through
mechanisms distal of increase of cytosolic calcium, such as the
myosin light chain kinase, which is inactivated by cAMP
dependent phosphorylation [30, 31].
The contraction of renal mesangial cells is considered as an
important determinant of glomerular filtration [32—341. Contrac-
tion of mesangial cells reduces the filtering surface resulting in
a decreased glomerular filtration rate. To analyze a possible
effect of CGRP on the glomerular filtration rate in an intact
kidney model, we have used the isolated perfused rat kidney.
This model was chosen to avoid possible indirect effects of
CGRP on renal function caused by stimulation of the central
nervous system [91, fall of blood pressure [10, 131 or stimulation
of the renin-angiotensin-aldosterone system [131. Effects of All
and CGRP on flow rate and glomerular filtration rate have been
examined at constant perfusion pressure. The present results
demonstrate that CGRP lowers renal vascular resistance, en-
hances glomerular filtration rate, and also filtration fraction.
The rise of filtration fraction could be brought about by in an
increase of intraglomerular perfusion pressure, or more likely
by an increase of glomerular hydraulic permeability due to an
increase of the filtering surface. This finding would thus be
compatible with a direct effect of CGRP on glomerular filtration
through interaction with mesangial cells. Our results also dem-
onstrate that CGRP is a potent vasodilator that antagonizes in
part the renal vasoconstrictory action of All. This finding
agrees with the observation that systemic application of CGRP
increases renal blood flow in rats [35]. The reduced but still
present action of angiotensin II during CORP infusion (Fig. 5)
may be due to submaximal amounts of CGRP or independent
effects of All.
We have recently shown that CGRP enhances renin release in
humans as well as from isolated rat renal juxtaglomerular cells
[131. Here we extended these findings and demonstrate in
perfused rat kidneys that CGRP also stimulates the release of
renin (Table 2).
CGRP is believed to act on its target cells by a local release
from nerve fibers [5, 12]. We and others have demonstrated the
120 presence of CGRP immunoreactive nerve fibers in the vicinity
of renal blood vessels and renal glomeruli [13, 36, 37]. This may
also indicate that CGRP physiologically regulates renal function
such as glomerular filtration, renal perfusion and the secretion
of renin.
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